Walleye Trading
PBYI icon

Walleye Trading’s Puma Biotechnology PBYI Stock Holding History

Walleye Trading’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,200
Closed -$89K – 4405
2019
Q4 		$89K Buy
10,200
+5,300
+108% +$43.9K ﹤0.01% 3608
2019
Q3 		$53K Sell
4,900
-40,200
-89% -$434K ﹤0.01% 3551
2019
Q2 		$573K Buy
45,100
+37,100
+464% +$854K ﹤0.01% 2086
2019
Q1 		$310K Buy
8,000
+300
+4% +$9.16K ﹤0.01% 2674
2018
Q4 		$157K Buy
7,700
+7,000
+1,000% +$210K ﹤0.01% 3605
2018
Q3 		$32K Buy
+700
New +$33.8K ﹤0.01% 4715

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Walleye Trading's PBYI Position: Q1 2022 in Review

Walleye Trading sold out of Puma Biotechnology (PBYI) in Q1 2022, closing a stake of 101,947 shares — an estimated $310K sold.

Walleye Trading first reported a position in PBYI in Q3 2016 and held it in 6 quarters. The position peaked at $406K in Q4 2019. 104 funds tracked by Wall St. Rank hold PBYI as of Q1 2022.

  • Walleye Trading reported no remaining Puma Biotechnology position as of Q1 2022 after selling out during the quarter.
  • Walleye Trading sold 101,947 Puma Biotechnology shares in Q1 2022, an estimated $310K.
  • Walleye Trading first reported a position in Puma Biotechnology in Q3 2016 and held it in 6 quarters.
  • Walleye Trading's Puma Biotechnology position peaked at $406K in Q4 2019.
  • 104 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.